These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17557273)

  • 1. Predicting risk selection following major changes in Medicare.
    Pizer SD; Frakt AB; Feldman R
    Health Econ; 2008 Apr; 17(4):453-68. PubMed ID: 17557273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficiary price sensitivity in the Medicare prescription drug plan market.
    Frakt AB; Pizer SD
    Health Econ; 2010 Jan; 19(1):88-100. PubMed ID: 19191252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.
    Cubanski J; Neuman P
    Health Aff (Millwood); 2007; 26(1):w1-12. PubMed ID: 17118944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attribute substitution in early enrollment decisions into Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Econ; 2008 Apr; 17(4):513-21. PubMed ID: 17935198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvements in Medicare Part D risk adjustment: beneficiary access and payment accuracy.
    Kautter J; Ingber M; Pope GC; Freeman S
    Med Care; 2012 Dec; 50(12):1102-8. PubMed ID: 22922436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost minimization of medicare part D prescription drug plan expenditures.
    Patel RA; Lipton HL; Cutler TW; Smith AR; Tsunoda SM; Stebbins MR
    Am J Manag Care; 2009 Aug; 15(8):545-53. PubMed ID: 19670958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in estimated Medicare prescription drug plan costs and affordability for beneficiaries living in different states.
    Davis MM; Patel MS; Halasyamani LK
    J Gen Intern Med; 2007 Feb; 22(2):257-63. PubMed ID: 17356996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should Medicare adopt the Veterans Health Administration formulary?
    Frakt AB; Pizer SD; Feldman R
    Health Econ; 2012 May; 21(5):485-95. PubMed ID: 21506191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D?
    Atherly A; Dowd B
    Health Econ; 2009 Aug; 18(8):921-31. PubMed ID: 18972327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why using current medications to select a medicare Part D plan may lead to higher out-of-pocket payments.
    Domino ME; Stearns SC; Norton EC; Yeh WS
    Med Care Res Rev; 2008 Feb; 65(1):114-26. PubMed ID: 17942795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare part D data: major changes on the horizon.
    Greenwald LM
    Med Care; 2007 Oct; 45(10 Supl 2):S9-12. PubMed ID: 17909390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biased enrollment of Medicare beneficiaries in HMO plans--implications for Medicare costs.
    Khan MM; Tsai WC; Kung PT
    J Health Care Finance; 2002; 28(4):43-57. PubMed ID: 12148663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of voluntary disenrollment from Medicare managed care.
    Ng JH; Kasper JD; Forrest CB; Bierman AS
    Med Care; 2007 Jun; 45(6):513-20. PubMed ID: 17515778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Market and beneficiary characteristics associated with enrollment in Medicare managed care plans and fee-for-service.
    Shimada SL; Zaslavsky AM; Zaborski LB; O'Malley AJ; Heller A; Cleary PD
    Med Care; 2009 May; 47(5):517-23. PubMed ID: 19365291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; modification to the weighting methodology used to calculate the low-income benchmark amount. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Apr; 73(65):18176-82. PubMed ID: 18464346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2007 costs and coverage of antiretrovirals under Medicare Part D for people with HIV/AIDS living in North Carolina.
    Sengupta S
    N C Med J; 2008; 69(1):6-13. PubMed ID: 18429558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the Medicare Part D prescription program: partnerships for beneficiaries and health care professionals.
    De Natale ML
    Policy Polit Nurs Pract; 2007 Aug; 8(3):170-81. PubMed ID: 18178923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voluntary disenrollment from Medicare advantage plans: valuable signals of market performance.
    Mobley LR; McCormack LA; Wang J; Squire C; Kenyon A; Lynch JT; Heller A
    Am J Manag Care; 2007 Dec; 13(12):677-84. PubMed ID: 18069911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of national annual variation in total patient out-of-pocket Medicare Part D stand-alone prescription drug plan costs from 2007 to 2008.
    Walberg MP; Patel RA; Amaral MM
    J Med Econ; 2008; 11(4):625-37. PubMed ID: 19450072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of insurance type on prescription drug use and expenditures among elderly Medicare beneficiaries.
    Saleh SS; Weller W; Hannan E
    J Health Hum Serv Adm; 2007; 30(1):50-74. PubMed ID: 17557696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.